The Patent Finder

Terms ending in 2039

CureVac AG

Every in-force patent on CureVac AG's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,747,451RNA Encoding an Antibody
In force
 · High confidence
CureVac SEIn forceHigh confidence
US 12,097,253RSV RNA Molecules and Compositions for Vaccination
In force
 · Medium confidence
CureVac SEIn forceMedium confidence
US 12,350,330RSV RNA Molecules and Compositions for Vaccination
In force
 · Medium confidence
CureVac SEIn forceMedium confidence
US 11,931,406Flavivirus Vaccine
In force
 · High confidence
Sanofi R&D VaccinsIn forceHigh confidence
US 11,478,552Hybrid Carriers for Nucleic Acid Cargo
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 12,508,308Influenza Mrna Vaccines
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,596,699RNA Encoding an Antibody
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,684,665Method for Producing RNA Molecule Compositions
In force
 · High confidence
Curevac SEIn forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited